Max Wallace Speaks at University of Virginia Innovation Roundtable

On March 17th, Max Wallace, biotech entrepreneur and CEO of Accelerate Brain Cancer Cure will lead a discussion on "Tight Roping the Valley of Death, Venture Philanthropy and Other Non-conventional Approaches to Funding Drug Development" at the University of Virginia's Innovation Roundtable Series.   Max will discuss the mission of Accelerate Brain Cancer Cure and its commitment to new models of collaboration among the many players dedicated to finding a cure for brain cancer.  The event takes place on Thursday, March 17th from 5:30 - 7pm at UVA's Colonnade Club.

UVA's Office of the VP for Innovation Partnerships and Commercialization recently launched this new monthly seminar series called “Innovation Roundtable” to engage entrepreneurs from the Charlottesville area to come listen, learn and network with other curious minded people in the community.

 

Share |
June 17, 2015 09:46 AM
These studies provide a foundational rationale for ABC2's efforts in the profiling space.
June 4, 2015 01:18 PM
An ABC2-funded brain cancer vaccine receives positive reviews at the American Society of Clinical Oncology annual meeting.
May 31, 2015 01:58 PM
Our deepest sympathies go out to his friends and family. 

Join us in our fight for a cure!

Twitter